Innovus Pharmaceuticals Reports Record Quarterly Revenue for the First Quarter 2018 of $4.5 million, Beating Previous Estimate and Net Loss Decrease of 28% Compared to the Same Quarterly Period in 201
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Innovus Pharmaceuticals, Inc. (NASDAQ: INNV) | Delayed: 9.23 +0.08 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.15 | 52 Week High | $0.66 | |||
| Open | $9.17 | 52 Week Low | $0.03 | |||
| Day High | $9.29 | P/E | N/A | |||
| Day Low | $9.04 | EPS | $-0.20 | |||
| Volume | 352,025 | |||||
